Search Stock:
Medicamen Biotech Share Price, Technical, Fundamental Analysis, Financials, Shareholding, RSI, MACD and Moving Averages
Price on NSE
Price on BSE
Medicamen Biotech (MEDICAMEQ) Key Ratios
P/E
Company33.07
Sector6.74
A Price-to-Earnings of 33.07 means investors pay 33.07 units per 1 unit of earnings. This is higher than the sector average of 6.74.
P/B
Company1.2
Sector4.35
A P/B ratio of 1.2 shows market value relative to book value. This is lower than the sector average of 4.35.
ROA
Company2.7%
Sector-17.9%
Return on Assets shows a 2.7% profit per unit of asset. This is lower than the sector average of -17.9%.
ROE
Company3.5%
Sector-3.17%
Return on Equity creates 3.5% profit per unit of equity. This is higher than the sector average of -3.17%.
ROCE
Company4.79%
Sector6.29%
ROCE indicates 4.79% operating earnings per unit of capital. This is lower than the sector average of 6.29%.
EV/EBITDA
Company14.32
Sector14.55
EV/EBITDA of 14.32 means value is 14.32 times core earnings. This is lower than the sector average of 14.55.
Medicamen Biotech Share Price Analysis Local DB
Medicamen Biotech share price is ₹265.25, day high (share price) is ₹270.90, day low (share price) is ₹259.05 and volume is 74,789. 52 Week high share price for Medicamen Biotech is ₹447.65 on 25 Nov 2025 and 52 week low share price for Medicamen Biotech is ₹212.40 on 29 Jun 2026. Price data as of: 02 Sep, 2026 3:31 PM.
According to latest price data (as of 02 Sep, 2026 3:31 PM) for Medicamen Biotech share, 14 day period RSI (Relative Strength Index) is 62.5, 50 DMA (50 Displaced Moving Average) is 242.15 and 200 DMA (200 Displaced Moving Average) is 296.48.
▼
₹265.25
-2.15 (-0.80%)
As of 02 Sep, 2026
Open
₹268.00
Day High - Low
₹270.90 - ₹259.05
Volume
74,789
52 Weeks High
₹447.65
on 25 Nov 2025
52 Weeks Low
₹212.40
on 29 Jun 2026
RSI (14)
62.5
50 DMA
242.15
200 DMA
296.48
Loading...
Medicamen Biotech (MEDICAMEQ) Technical Analysis
₹265.25
-2.15
02 Sep, 2026
Medicamen Biotech Technical Data and Analysis available in multiple timeframes.
Medicamen Biotech Oscillators Analysis
On the Day timeframe, the outlook for MEDICAMEQ is: The long-term trend is Negative (Price vs 200 SMA) and RSI (14) is: 62.5.
Medicamen Biotech Price Action
Medicamen Biotech Oscillators Overview
| Indicator | Value |
|---|---|
| RSI (14) | 62.54 |
| Stoch %K (14, 3, 3) | 84.44 |
| CCI (20) | 220.60 |
| ADX (14) | 13.68 |
| Awesome Osc | 11.24 |
| Momentum (10) | 36.52 |
| MACD (12, 26, 9) | 4.81 |
| MACD Signal | 1.02 |
| Stoch RSI (14) | 98.29 |
| Williams %R (14) | -21.48 |
| Bull/Bear Power | 33.93 |
| Ultimate Osc | 61.65 |
| MFI (14) | 65.96 |
| ROC (21) | 5.75 |
| ROC (125) | -11.94 |
| ATR (14) | 13.46 |
Medicamen Biotech Moving Averages
MEDICAMEQ is trading above 12 out of 14 SMAs.
265.25
CURRENT PRICE
Bullish Moving Averages
12
Bearish Moving Averages
2
5 SMA254.75
8 SMA248.23
9 SMA247.82
10 SMA247.42
12 SMA244.05
20 SMA240.79
21 SMA240.90
26 SMA240.69
30 SMA240.59
34 SMA240.80
50 SMA242.15
100 SMA249.85
150 SMA266.15
200 SMA296.48
| Ichimoku Base | 247.00 | Above Base |
| VWMA (20) | 248.99 | Above VWMA |
| HMA (9) | 268.53 | Below HMA |
Medicamen Biotech Technical SWOT Analysis
STRENGTHS
- Price is above the 50 DMA, suggesting supportive medium-term trend structure.
- MACD is above the signal line and in positive territory, reflecting supportive momentum.
- RSI at 62.54 indicates relatively strong momentum without being overbought.
WEAKNESSES
- Price is trading below the 200 DMA, indicating relatively weaker long-term structure.
OPPORTUNITIES
- No specific opportunity signals are identified; the setup appears neutral.
THREATS
- Price is near the upper Bollinger Band, which can indicate strong momentum or possible exhaustion.
Medicamen Biotech Daily Pivot Points (Support & Resistance)
| Level | Classic | Woodie's | Camarilla | Fibonacci |
|---|---|---|---|---|
| Resistance 3 | 297.87 | 297.93 | 272.89 | 288.43 |
| Resistance 2 | 288.43 | 288.46 | 271.06 | 280.81 |
| Resistance 1 | 277.92 | 277.98 | 269.23 | 276.10 |
| Pivot Point | 268.48 | 268.51 | 267.40 | 268.48 |
| Support 1 | 257.97 | 258.03 | 265.57 | 260.86 |
| Support 2 | 248.53 | 248.56 | 263.74 | 256.15 |
| Support 3 | 238.02 | 238.08 | 261.91 | 248.53 |
Records:
| Date | Close | ADX | PDI | MDI | Aroon Up | Aroon Down | Bollinger UB | Bollinger MB | Bollinger LB | CCI | CMF | MACD | Signal | MFI | PSAR | RSI (F) | RSI | Sto (F) %K | %D | Supertrend | Ult Osc | Wil %R |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synchronizing oscillators history... | ||||||||||||||||||||||
Records:
| Date | Close | SMA(5) | EMA(5) | SMA(8) | EMA(8) | SMA(9) | EMA(9) | SMA(10) | EMA(10) | SMA(12) | EMA(12) | SMA(20) | EMA(20) | SMA(21) | EMA(21) | SMA(26) | EMA(26) | SMA(30) | EMA(30) | SMA(34) | EMA(34) | SMA(50) | EMA(50) | SMA(100) | EMA(100) | SMA(150) | EMA(150) | SMA(200) | EMA(200) | Ichimoku Base | VWMA(20) | HMA(9) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synchronizing moving averages history... | ||||||||||||||||||||||||||||||||
Medicamen Biotech - Shareholding Pattern
Historical breakdown of ownership percentages over time.
| Category | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Promoters | 40.46% | 40.46% | 40.46% | 40.46% |
| FII | 0.07% | 0.10% | 0.02% | 0.06% |
| DII (Other) | 0.40% | 0.00% | 0.44% | 0.59% |
| Retail & Others | 59.07% | 59.45% | 59.08% | 58.90% |
| Mutual Funds | 0.00% | 0.00% | 0.00% | 0.00% |
Medicamen Biotech - Yearly Income Statement (in ₹ Crore)
| Period | Revenue | Operating Profit | Net Profit |
|---|---|---|---|
| Mar 2026 | 200.88 +19.01% | 11.98 +21.26% | 9.80 +49.39% |
| Mar 2025 | 168.79 -7.07% | 9.88 -24.46% | 6.56 -30.87% |
| Mar 2024 | 181.64 +26.73% | 13.08 -23.28% | 9.49 -35.57% |
| Mar 2023 | 143.33 | 17.05 | 14.73 |
Medicamen Biotech - Corporate Actions
| Type | Ex-Date | Amount / Ratio | Details |
|---|---|---|---|
| Dividend | 19 Sep 2025 | ₹1 | View Details |
|
Announcement date
30 May 2025
Ex dividend date
19 Sep 2025
Record date
19 Sep 2025
Dividend type
Final
Amount
1.0
Dividend %
10.0
Details
Rs.1.0000 per share(10%)Final Dividend (RD & XD dates revised)
|
|||
Medicamen Biotech Share Price and Volume Historical Data
Synchronizing MarketBandhu Database...
